---
title: "Abivax's Options: A Look at What the Big Money is Thinking"
description: "Investors are taking a bearish stance on Abivax (NASDAQ:ABVX), with 50% of big-money traders showing bearish sentiment. Recent options activity revealed 12 trades, including 1 put worth $31,360 and 11"
type: "news"
locale: "en"
url: "https://longbridge.com/en/news/272590607.md"
published_at: "2026-01-14T18:01:20.000Z"
---

# Abivax's Options: A Look at What the Big Money is Thinking

> Investors are taking a bearish stance on Abivax (NASDAQ:ABVX), with 50% of big-money traders showing bearish sentiment. Recent options activity revealed 12 trades, including 1 put worth $31,360 and 11 calls totaling $605,529. The expected price range for Abivax is between $90.0 and $175.0. Currently, ABVX is trading at $121.22, up 1.32%. Analysts have set an average price target of $142.0, with ratings ranging from Market Outperform to Buy, indicating potential for growth despite the bearish options sentiment.

Investors with a lot of money to spend have taken a bearish stance on **Abivax** (NASDAQ:ABVX).

And retail traders should know.

We noticed this today when the positions showed up on publicly available options history that we track here at Benzinga.

Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with ABVX, it often means somebody knows something is about to happen.

Today, Benzinga's options scanner spotted 12 options trades for **Abivax**.

This isn't normal.

The overall sentiment of these big-money traders is split between 41% bullish and 50%, bearish.

Out of all of the options we uncovered, there was 1 put, for a total amount of $31,360, and 11, calls, for a total amount of $605,529.

### Expected Price Movements

Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $90.0 to $175.0 for Abivax during the past quarter.

### Volume & Open Interest Trends

Looking at the volume and open interest is a powerful move while trading options. This data can help you track the liquidity and interest for Abivax's options for a given strike price. Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Abivax's whale trades within a strike price range from $90.0 to $175.0 in the last 30 days.

### Abivax 30-Day Option Volume & Interest Snapshot

![Options Call Chart](https://imageproxy.pbkrs.com/https://www.benzinga.com/files/images/story/2026/1768413676_0.png?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg)

### Biggest Options Spotted:

**Symbol**

**PUT/CALL**

**Trade Type**

**Sentiment**

**Exp. Date**

**Ask**

**Bid**

**Price**

**Strike Price**

**Total Trade Price**

**Open Interest**

**Volume**

ABVX

CALL

SWEEP

BEARISH

01/16/26

$5.6

$5.5

$5.5

$125.00

$147.9K

533

292

ABVX

CALL

SWEEP

BULLISH

02/20/26

$17.0

$13.5

$15.0

$130.00

$108.0K

465

100

ABVX

CALL

TRADE

BEARISH

02/20/26

$11.0

$10.0

$10.0

$150.00

$88.0K

1.9K

216

ABVX

CALL

TRADE

BEARISH

03/20/26

$28.9

$25.5

$26.63

$110.00

$39.9K

10

15

ABVX

CALL

TRADE

BULLISH

01/16/26

$14.9

$13.4

$14.9

$110.00

$37.2K

1.1K

173

### About Abivax

Abivax SA is a France-based clinical-stage biotechnology company focused on developing therapeutics that harness the body's natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. Company is evaluating its drug candidate, obefazimod, in Phase 3 clinical trials for the treatment of adults with moderately to severely active ulcerative colitis. Its initial focus is on inflammatory bowel diseases, chronic conditions involving inflammation of the gastrointestinal tract, of which the two common forms are UC and CD.

In light of the recent options history for Abivax, it's now appropriate to focus on the company itself. We aim to explore its current performance.

### Current Position of Abivax

-   Currently trading with a volume of 1,013,271, the ABVX's price is up by 1.32%, now at $121.22.
-   RSI readings suggest the stock is currently may be approaching overbought.
-   Anticipated earnings release is in 68 days.

### Expert Opinions on Abivax

A total of 3 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $142.0.

-   Maintaining their stance, an analyst from Citizens continues to hold a Market Outperform rating for Abivax, targeting a price of $131.
-   An analyst from BTIG persists with their Buy rating on Abivax, maintaining a target price of $150.
-   An analyst from Morgan Stanley has decided to maintain their Overweight rating on Abivax, which currently sits at a price target of $145.

Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics.

### Related Stocks

- [ABVX.US - Abivax SA](https://longbridge.com/en/quote/ABVX.US.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| 美股夜盘异动：分析师看好与药物潜力双重利好，Abivax SA 夜盘涨 9.27% | Abivax SA 夜盘涨 9.27%；Recursion Pharmaceuticals 夜盘涨 1.50%，成交额达到 2.16 百万美元；Mereo Biopharma 夜盘涨 15.33%，成交额达到 1.35 百万美元；百济神州夜 | [Link](https://longbridge.com/en/news/272222956.md) |
| 美股盘中速递：分析师上调目标价难救市，Abivax SA 股价跌 10.99% | Abivax SA 跌 10.99%；艾伯维跌 3.93%，成交额达到 10.64 亿美元；Revolution Medicines 跌 5.55%，成交额达到 4.76 亿美元；安进跌 3.08%，成交额达到 4.39 亿美元；吉利德科学 | [Link](https://longbridge.com/en/news/271973228.md) |
| 美股夜盘异动：Abivax SA 夜盘涨 7.61%，交易活跃但缺乏重要新闻，市场情绪何去何从？ | Abivax SA 夜盘涨 7.61%；ImmunityBio 夜盘涨 10.51%，成交额达到 18.95 百万美元；Recursion Pharmaceuticals 夜盘跌 3.85%，成交额达到 2.48 百万美元；百济神州夜盘跌  | [Link](https://longbridge.com/en/news/273047886.md) |
| 由于对 Eli Lilly 收购的猜测，Abivax 的股票飙升了 30% | Abivax 的股票在巴黎早盘交易中上涨了 30%，原因是有报道称礼来公司正在准备一项 150 亿欧元的收购提议。这一举动几乎将 Abivax 的市值翻倍，并反映了投资者对其主要药物 obefazimod 的信心，该药物在治疗溃疡性结肠炎方 | [Link](https://longbridge.com/en/news/272288126.md) |
| 美股盘前热门交易：X3 盘前涨 14.41%；Abivax SA 盘前涨 7.19% | X3 盘前涨 14.41%；Abivax SA 盘前涨 7.19%；Agape ATP 盘前涨 60.71%；Mingteng 盘前涨 40.23%；BRC 盘前涨 34.88%。 | [Link](https://longbridge.com/en/news/272682089.md) |

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.
